March 27, 2023

Myeloma Patients Europe appoints joint CEOs

Myeloma Patients Europe (MPE) is pleased to announce that Katie Joyner and Kate Morgan have been appointed as joint Chief Executive Officers (CEO). The MPE Board of Directors unanimously made this decision based on the impressive work and leadership both have shown during the transition period following the stepping down of founding CEO, Ananda Plate.

Myeloma Patients Europe appoints joint CEOs

Myeloma Patients Europe (MPE) is pleased to announce that Katie Joyner and Kate Morgan have been appointed as joint Chief Executive Officers (CEO). The MPE Board of Directors unanimously made this decision based on the impressive work and leadership both have shown during the transition period following the stepping down of founding CEO, Ananda Plate.

For the past year, Katie and Kate have served as the Chief Operating Officer (COO) and the Chief Strategy Officer (CSO) respectively, leading the day-to-day management of the organisation and responsible for the overall strategy, along with the Board.

Lise-Lott Eriksson, President of MPE commented:

“The MPE Board is delighted to announce the appointment of Kate and Katie as joint CEOs. The amazing work they have done during this transition period, and the unique expertise both bring to the position, make them a perfect fit. They know MPE inside and out, and have continued to build upon on our achievements over the past year. We believe MPE will start a new and successful cycle under the leadership of Katie and Kate”.

Learn more about Katie and Kate’s background in the section “Our board and staff”.

If you have any questions or comments about the appointment, please email info@mpeurope.org

Katie Joyner

Kate Morgan